Search bioRxiv⌕ Search

Biology subjects

Schminke, S.

Publications and source records attributed to Schminke, S..

2 recordsLinked to original sources

Chaperone structure is not a sufficient determinant for the hierarchy of substrate secretion in bacterial type III secretion systems

Functional type III secretion in Gram negative bacteria relies on precise substrate targeting and a strict order of secretion with early, intermediate, and late substrates. Type III secretion chaperones facilitate these processes by maintaining substrates in a partially unfolded, secretion-competent state and serving as order-specific targeting factors. Early needle filament assembling substrates are chaperoned by none or class III chaperones, intermediate translocator-type substrates by class II and late effector-type substrates by class I chaperones. In case of hydrophobic transmembrane effectors, chaperones may also serve to prevent erroneous mistargeting of these substrates to the bacterial inner membrane. Here, we characterized the Salmonella transmembrane effectors SseF and SseG and their chaperone SscB, encoded in the operon sscB-sseF-sseG, in order to gain a deeper understanding of the underlying molecular requirements of targeting of this special class of substrates. We show that the gene linkage of SscB and SseF is critical for these proteins stability and SseF secretion. Counterintuitively, SscB revealed to feature a class II chaperone structure with a class I chaperone function. Likewise, SseF and SseG harbour conserved, translocator-like chaperone-binding motifs (PXI/LXXP) but were secreted as late substrates, independent of the gatekeeper protein SsaL. These findings challenge the current chaperone classification and our understanding of the molecular basis of the hierarchy of substrate secretion. They show that chaperone structure is not a sufficient molecular determinant for the correct order of substrate secretion.

microbiology↗

Discovery of a synthetic small molecule targeting the central regulator of Salmonella pathogenicity

The enteric pathogen Salmonella enterica serovar Typhimurium relies on the activity of effector proteins to invade, replicate, and disseminate into host epithelial cells and other tissues, thereby causing disease. Secretion and injection of effector proteins into host cells is mediated by dedicated secretion systems, which hence represent major virulence determinants. Here, we report the identification of a synthetic small molecule with drug-like properties, C26, which suppresses the secretion of effector proteins, and consequently hinders bacterial invasion of eukaryotic cells. C26 binds to and inhibits HilD, the transcriptional regulator of the major secretion systems. While sharing the same binding pocket as the previously described long-chain fatty acid ligands, C26 inhibits HilD with a unique binding mode and a distinct mechanism. We provide evidence for target engagement within infected eukaryotic cells and present analogs with improved potency and suitability as scaffolds to develop anti-virulence agents against Salmonella infections in humans and animals.

microbiology↗